Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2010 1
2011 2
2012 1
2014 1
2016 3
2017 5
2018 5
2019 5
2020 1
2021 2
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for eleni liver
Your search for Eleni Liveri retrieved no results
Mechanisms of sarcopenia in liver cirrhosis and the role of myokines.
Geladari E, Alexopoulos T, Kontogianni MD, Vasilieva L, Mani I, Alexopoulou A. Geladari E, et al. Ann Gastroenterol. 2023 Jul-Aug;36(4):392-404. doi: 10.20524/aog.2023.0804. Epub 2023 May 29. Ann Gastroenterol. 2023. PMID: 37396001 Free PMC article. Review.
It is not identical to frailty and malnutrition, even though there is a significant overlap among these syndromes. In patients with liver cirrhosis (LC), sarcopenia is classified as secondary and has been associated with increased morbidity and mortality during the pre- an …
It is not identical to frailty and malnutrition, even though there is a significant overlap among these syndromes. In patients with liver …
Anticoagulation in patients with atrial fibrillation and liver cirrhosis.
Karapedi E, Papadopoulos N, Trifylli EM, Koustas E, Deutsch M, Aloizos G. Karapedi E, et al. Ann Gastroenterol. 2022 Nov-Dec;35(6):557-567. doi: 10.20524/aog.2022.0745. Epub 2022 Oct 3. Ann Gastroenterol. 2022. PMID: 36406965 Free PMC article. Review.
Atrial fibrillation (AF) is an increasingly recognized comorbidity in patients with liver cirrhosis, mainly associated with nonalcoholic fatty liver disease and alcohol-associated liver disease, affecting the quality of life and prognosis. ...However, there i …
Atrial fibrillation (AF) is an increasingly recognized comorbidity in patients with liver cirrhosis, mainly associated with nonalcoho …
Infections in severe alcoholic hepatitis.
Karakike E, Moreno C, Gustot T. Karakike E, et al. Ann Gastroenterol. 2017;30(2):152-160. doi: 10.20524/aog.2016.0101. Epub 2016 Oct 27. Ann Gastroenterol. 2017. PMID: 28243035 Free PMC article. Review.
Severe alcoholic hepatitis (sAH), defined by a modified discriminant function 32, is the most severe form of alcohol-induced liver disease and is associated with a 1-month mortality rate of around 30%. ...Infectious complications, occurring in approximately 50% of patients …
Severe alcoholic hepatitis (sAH), defined by a modified discriminant function 32, is the most severe form of alcohol-induced liver di …
Endoscopic ultrasound-guided tissue acquisition beyond the pancreas.
Manthopoulou E, Ramai D, Ioannou A, Gkolfakis P, Papanikolaou IS, Mangiavillano B, Triantafyllou K, Crinò SF, Facciorusso A. Manthopoulou E, et al. Ann Gastroenterol. 2023 May-Jun;36(3):257-266. doi: 10.20524/aog.2023.0797. Epub 2023 Apr 8. Ann Gastroenterol. 2023. PMID: 37144012 Free PMC article. Review.
This paper aims to review the literature on EUS tissue acquisition in other organs (beyond the pancreas) such as the liver, biliary tree, lymph nodes, and upper and lower gastrointestinal tracts. ...
This paper aims to review the literature on EUS tissue acquisition in other organs (beyond the pancreas) such as the liver, biliary t …
Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
Liapi E, Geschwind JF. Liapi E, et al. Cardiovasc Intervent Radiol. 2011 Feb;34(1):37-49. doi: 10.1007/s00270-010-0012-y. Epub 2010 Nov 12. Cardiovasc Intervent Radiol. 2011. PMID: 21069333 Free PMC article. Review.
As both therapies continue to being tested in many phase II and III studies and in combination with other therapies, especially targeted agents, for treatment of primary and metastatic liver cancer, it is imperative to review their current status and evaluate their impact …
As both therapies continue to being tested in many phase II and III studies and in combination with other therapies, especially targeted age …
Repeated SBRT for in- and out-of-field recurrences in the liver.
Gkika E, Strouthos I, Kirste S, Adebahr S, Schultheiss M, Bettinger D, Fritsch R, Brass V, Maruschke L, Neeff HP, Lang SA, Nestle U, Grosu AL, Brunner TB. Gkika E, et al. Strahlenther Onkol. 2019 Mar;195(3):246-253. doi: 10.1007/s00066-018-1385-0. Epub 2018 Oct 23. Strahlenther Onkol. 2019. PMID: 30353350 English.
There were no elevations of the serum liver parameters after re-SBRT. One patient developed a grade 3 gastrointestinal bleeding. There was no radiation induced liver disease (RILD) observed. CONCLUSIONS: Repeated liver SBRT is feasible, without excessive l …
There were no elevations of the serum liver parameters after re-SBRT. One patient developed a grade 3 gastrointestinal bleeding. Ther …
Host and microbiome multi-omics integration: applications and methodologies.
Wang Q, Wang K, Wu W, Giannoulatou E, Ho JWK, Li L. Wang Q, et al. Biophys Rev. 2019 Feb;11(1):55-65. doi: 10.1007/s12551-018-0491-7. Epub 2019 Jan 9. Biophys Rev. 2019. PMID: 30627872 Free PMC article. Review.
It is increasingly clear that the composition of the human's microbiome is associated with various diseases such as gastrointestinal diseases, liver diseases and metabolic diseases. Using high-throughput technologies such as next-generation sequencing and mass spectrometry …
It is increasingly clear that the composition of the human's microbiome is associated with various diseases such as gastrointestinal disease …
Correspondence on Rajyaguru et al.
Boda-Heggemann J, Gkika E, Andratschke N, Blanck O, Guckenberger M, Lohr F, Brunner TB. Boda-Heggemann J, et al. J Clin Oncol. 2018 Aug 20;36(24):2561-2562. doi: 10.1200/JCO.2018.78.1542. Epub 2018 Jun 26. J Clin Oncol. 2018. PMID: 29945524 Free article. No abstract available.
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.
Petros Z, Lee MM, Takahashi A, Zhang Y, Yimer G, Habtewold A, Amogne W, Aderaye G, Schuppe-Koistinen I, Mushiroda T, Makonnen E, Kubo M, Aklillu E. Petros Z, et al. BMC Genomics. 2016 Sep 26;17(1):755. doi: 10.1186/s12864-016-3078-3. BMC Genomics. 2016. PMID: 27671213 Free PMC article.
BACKGROUND: Drug-induced liver injury (DILI) is a well-recognized adverse event of anti tuberculosis drugs (ATD) possibly associated with genetic variations. ...CONCLUSION: We identified genetic variants that are potentially associated with ATD induced liver toxicit …
BACKGROUND: Drug-induced liver injury (DILI) is a well-recognized adverse event of anti tuberculosis drugs (ATD) possibly associated …
Everolimus with or without mycophenolate mofetil in a liver transplantation setting: a single-center experience.
Cholongitas Ε, Goulis I, Theocharidou E, Antoniadis N, Fouzas I, Imvrios G, Giouleme O, Angelaki A, Vasiliadis T, Papanikolaou V, Akriviadis E. Cholongitas Ε, et al. Ann Gastroenterol. 2018 Sep-Oct;31(5):613-620. doi: 10.20524/aog.2018.0278. Epub 2018 May 25. Ann Gastroenterol. 2018. PMID: 30174399 Free PMC article.
BACKGROUND: This study evaluated the efficacy, safety, and impact on renal function of everolimus in patients after liver transplantation (LT) with or without mycophenolate mofetil (MMF). ...
BACKGROUND: This study evaluated the efficacy, safety, and impact on renal function of everolimus in patients after liver transplanta …
34 results